DIRS.INFO The most relevant business & tech news

Public safety officials in England, France and Spain said Tuesday that they would step up security for matches this week in the Champions League, Europe’s marquee soccer competition, after ISIS-related groups called for violent attacks on the contests. The first of four quarterfinal matchups were scheduled in London and Madrid on Tuesday, and were to feature some of the top clubs in world soccer: Spain’s Real Madrid; the English giants Arsenal and Manchester City; and Germany’s Bayern Munich. Two other high-profile matches will take place on Wednesday in Paris and Madrid. “We don’t know what location might be particularly targeted, neither in what conditions,” the French interior minister, Gérald Darmanin, told reporters in Paris. The ministry said security measures at the matches in Madrid had been increased and additional agents deployed.

Persons: Gérald Darmanin Organizations: Champions League, ISIS, Spain’s, Arsenal, Manchester City, Germany’s Bayern Munich, ”, El Mundo Locations: England, France, Spain, London, Madrid, Spain’s Real Madrid, Paris, Spanish, El

[1/4] Diet Coke is seen on display at a store in New York City, U.S., June 28, 2023. Aspartame, used in products from Coca-Cola diet sodas to Mars' Extra chewing gum and some Snapple drinks, will be listed in July as "possibly carcinogenic to humans" for the first time by the International Agency for Research on Cancer (IARC), the World Health Organization's (WHO) cancer research arm, the sources said. Pepsico removed aspartame from sodas in 2015, bringing it back a year later, only to remove it again in 2020. Listing aspartame as a possible carcinogen is intended to motivate more research, said the sources close to the IARC, which will help agencies, consumers and manufacturers draw firmer conclusions. But it will also likely ignite debate once again over the IARC's role, as well as the safety of sweeteners more generally.

Persons: Coke, Shannon Stapleton, Health Organization's, JECFA, Nozomi Tomita, Zsuzsanna, Germany’s Bayer, Frances Hunt, Wood, Mars Wrigley, Kate Loatman, –, Jennifer Rigby, Richa Naidu, Michele Gershberg, Mark Potter Organizations: REUTERS, International Agency for Research, Cancer, Health, Joint WHO, Food, Agriculture Organization's, WHO, Reuters, Japan's Ministry of Health, Labour, Welfare, Food Safety Authority, U.S, International, Association, Cargill, International Council of Beverages Associations, Ramazzini Institute, EFSA, Pepsico, Thomson Locations: New York City, U.S, United States, Europe, Geneva, France, Italy, sodas

JECFA, the WHO committee on additives, is also reviewing aspartame use this year. The first group includes substances from processed meat to asbestos, which all have convincing evidence showing they cause cancer, IARC says. Like aspartame, this means there is either limited evidence they can cause cancer in humans, sufficient evidence in animals, or strong evidence about the characteristics. Pepsico removed aspartame from sodas in 2015, bringing it back a year later, only to remove it again in 2020. Listing aspartame as a possible carcinogen is intended to motivate more research, said the sources close to the IARC, which will help agencies, consumers and manufacturers draw firmer conclusions.

Persons: Coke, Shannon Stapleton, Health Organization's, JECFA, Nozomi Tomita, Zsuzsanna, Germany’s Bayer, IARC, Frances Hunt, Wood, Mars Wrigley, Kate Loatman, –, Jennifer Rigby, Richa Naidu, Michele Gershberg, Mark Potter, Susan Fenton Organizations: REUTERS, International Agency for Research, Cancer, Health, Reuters, Joint WHO, Food, Agriculture Organization's, WHO, Japan's Ministry of Health, Labour, Welfare, Food Safety Authority, U.S, International, Association, Cargill, International Council of Beverages Associations, Ramazzini Institute, EFSA, Pepsico, Thomson Locations: New York City, U.S, United States, Europe, Geneva, France, Italy, sodas

☆ Big Pharma’s heartburn win is a valuation salve
▼ + stars: | 2022-12-07 | by ( Aimee Donnellan | ) www.reuters.com time to read: +3 min

The equity value of GSK (GSK.L), Sanofi (SASY.PA) and Haleon (HLN.L) crashed in August, after analysts warned of a massive thwack linked to claims that heartburn medication Zantac caused cancer. On Tuesday, a Florida judge broadly agreed and threw out roughly 50,000 claims in federal court. Morgan Stanley analysts had estimated the overall Zantac litigation hit could have been as high as $45 billion. The Zantac judge has just proved that courts can be a help as well as a hindrance. Shares in GSK were up 9% to 15.08 pounds as of 0958 GMT on Dec. 7, while Sanofi rose 5% to 90.03 euros.

Search resuls for: "Germany’s Bayer"

4 mentions found